<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of the present study was to define <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> based on characterization of GAD antibodies (GADAs) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Patients enrolled in a nationwide survey, the Non Insulin Requiring Autoimmune <z:mp ids='MP_0002055'>Diabetes</z:mp> (NIRAD) Study, have been screened for GADAs and IA-2 antibodies (IA-2As) and further characterized for GADA titer, antibodies to thyroid peroxidase (TPO), and HLA DRB1-DQB1 polymorphisms </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Of 4,250 consecutive type 2 diabetic patients, 4.5% had either GADAs and/or IA-2As </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> showed a clinical phenotype significantly different from that of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, including higher fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and A1C, lower BMI and <z:chebi fb="3" ids="27226">uric acid</z:chebi>, lower prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its components, and higher frequency of TPO antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>More interestingly, analysis of GADA titers showed a bimodal distribution that identified two subgroups of patients with high (&gt;32 GADA arbitrary units) and low (&lt; or =32 GADA arbitrary units) GADA titers </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with those with low GADA titers, patients with high GADA titers had more prominent traits of insulin deficiency and a profile of more severe <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> resulting in higher A1C, lower BMI, a lower prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its components (P &lt; 0.02 for <z:hpo ids='HP_0000001'>all</z:hpo>), a higher prevalence of IA-2As, TPO antibodies (P &lt; 0.003 for both), and DRB1*03-DQB1*0201 (50 vs. 26.8%, P = 0.001), and a decreasing frequency of DQB1*0602 and DRB1*0403 (from type 2 to low and to high GADA titer autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>; P &lt; 0.001 for trend for both comparisons) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: GADA titers identify two subgroups of patients with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> having distinct clinical, autoimmune, and genetic features </plain></SENT>
</text></document>